These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 30419887)

  • 1. Changes in renal papillary density after hydration therapy in calcium stone formers.
    Ferraro PM; Vittori M; Macis G; D'Addessi A; Lombardi G; Palmisano C; Gervasoni J; Primiano A; Bassi PF; Gambaro G
    BMC Urol; 2018 Nov; 18(1):101. PubMed ID: 30419887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in computed tomography density of the renal papillae of stone formers and non-stone-formers: a pilot study.
    Eisner BH; Iqbal A; Namasivayam S; Catalano O; Kambadakone A; Dretler SP; Sahani DV
    J Endourol; 2008 Oct; 22(10):2207-10. PubMed ID: 18831676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic evidence of calculus attachment to Randall's plaque.
    Matlaga BR; Williams JC; Kim SC; Kuo RL; Evan AP; Bledsoe SB; Coe FL; Worcester EM; Munch LC; Lingeman JE
    J Urol; 2006 May; 175(5):1720-4; discussion 1724. PubMed ID: 16600740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Randall's Plaque Stone Anchors and Renal Papillary Pits.
    Borofsky MS; Williams JC; Dauw CA; Cohen A; Evan AC; Coe FL; Worcester E; Lingeman JE
    J Endourol; 2019 Apr; 33(4):337-342. PubMed ID: 30793930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hounsfield density of renal papillae in stone formers: analysis based on stone composition.
    Deshmukh S; Kambadakone A; Sahani DV; Eisner BH
    J Urol; 2015 May; 193(5):1560-3. PubMed ID: 25444988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinguishing characteristics of idiopathic calcium oxalate kidney stone formers with low amounts of Randall's plaque.
    Wang X; Krambeck AE; Williams JC; Tang X; Rule AD; Zhao F; Bergstralh E; Haskic Z; Edeh S; Holmes DR; Herrera Hernandez LP; Lieske JC
    Clin J Am Soc Nephrol; 2014 Oct; 9(10):1757-63. PubMed ID: 25092598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kidney stone formers have more renal parenchymal crystals than non-stone formers, particularly in the papilla region.
    Okada A; Hamamoto S; Taguchi K; Unno R; Sugino T; Ando R; Mizuno K; Tozawa K; Kohri K; Yasui T
    BMC Urol; 2018 Mar; 18(1):19. PubMed ID: 29530009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helper T-cell signaling and inflammatory pathway lead to formation of calcium phosphate but not calcium oxalate stones on Randall's plaques.
    Taguchi K; Hamamoto S; Okada A; Sugino T; Unno R; Ando R; Gao B; Tozawa K; Kohri K; Yasui T
    Int J Urol; 2019 Jun; 26(6):670-677. PubMed ID: 30919502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of renal papillae in kidney stone formers.
    Marien TP; Miller NL
    Minerva Urol Nefrol; 2016 Dec; 68(6):496-515. PubMed ID: 27441596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of endoscopic lesions of the renal papilla with type of renal stone and 24 h urine analysis.
    Sabaté Arroyo XA; Grases Freixedas F; Bauzà Quetglas JL; Guimerà Garcia J; Pieras Ayala E
    BMC Urol; 2020 Apr; 20(1):46. PubMed ID: 32334600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal papillary attenuation differences between primary and recurrent idiopathic calcium stone disease patients.
    Cakiroglu B; Eyyupoglu SE; Tas T; Esen T; Acar O; Aksoy SH
    Minerva Urol Nefrol; 2014 Jun; 66(2):107-12. PubMed ID: 24988201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased renal papillary density in kidney stone formers detectable by CT scan is a potential marker of stone risk, but is unrelated to underlying hypercalciuria.
    Shavit L; Girfoglio D; Kirkham A; Allen D; Ferraro PM; Moochhala S; Unwin R
    Urolithiasis; 2016 Oct; 44(5):471-5. PubMed ID: 27023714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urine calcium and volume predict coverage of renal papilla by Randall's plaque.
    Kuo RL; Lingeman JE; Evan AP; Paterson RF; Parks JH; Bledsoe SB; Munch LC; Coe FL
    Kidney Int; 2003 Dec; 64(6):2150-4. PubMed ID: 14633137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In idiopathic calcium oxalate stone-formers, unattached stones show evidence of having originated as attached stones on Randall's plaque.
    Miller NL; Williams JC; Evan AP; Bledsoe SB; Coe FL; Worcester EM; Munch LC; Handa SE; Lingeman JE
    BJU Int; 2010 Jan; 105(2):242-5. PubMed ID: 19549258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of Randall's plaques in the pathogenesis of calcium stones.
    Matlaga BR; Coe FL; Evan AP; Lingeman JE
    J Urol; 2007 Jan; 177(1):31-8. PubMed ID: 17161996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation analysis between renal papillae Hounsfield density (PHD) and endoscopic papillary description in stone formers.
    Almeras C; Assoun J; Baboudjian M; Touzani A; Pradere B
    Sci Rep; 2024 Aug; 14(1):18582. PubMed ID: 39127767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stone Morphology Distinguishes Two Pathways of Idiopathic Calcium Oxalate Stone Pathogenesis.
    Williams JC; Al-Awadi H; Muthenini M; Bledsoe SB; El-Achkar T; Evan AP; Coe F; Lingeman JE; Worcester EM
    J Endourol; 2022 May; 36(5):694-702. PubMed ID: 34915736
    [No Abstract]   [Full Text] [Related]  

  • 19. [Expression of matrix Gla protein and bone morphogenetic protein 2 in renal papillary tissues in patients with calcium oxalate kidney stones].
    Zhu M; Zeng F; Cui Y; Liu X; Chen H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Mar; 42(3):277-283. PubMed ID: 28364100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrasting histopathology and crystal deposits in kidneys of idiopathic stone formers who produce hydroxy apatite, brushite, or calcium oxalate stones.
    Evan AP; Lingeman JE; Worcester EM; Sommer AJ; Phillips CL; Williams JC; Coe FL
    Anat Rec (Hoboken); 2014 Apr; 297(4):731-48. PubMed ID: 24478243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.